BrainsWay Ltd. (BWAY)

NGM – Цена в реальном времени. Валюта: USD

16.74

+0.01 (0.06%)

При закрытии: May 12, 2026, 4:00 PM EDT

16.74

0.00 (0.00%)

После закрытия: May 12, 2026, 5:42 PM EDT

04.05.2026

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and CG Oncology, Inc. (CGON) have performed compared to their sector so far this year.

29.04.2026

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

29.04.2026

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today announced that it will report its first quarter 2026 financial results and recent operational highlights before the open of the U.S. financial markets on Wednesday, May 13, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

27.04.2026

4 Medical Product Stocks to Buy From a Challenging Industry

The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.

24.04.2026

BrainsWay: Competitive Threats Are Mounting

BrainsWay continues to deliver strong growth and margin improvement, supported by investments in TMS service providers and recurring revenue expansion. BWAY's accelerated protocol and expanded indications, including adolescent depression, are supportive of further growth. TMS is a relatively expensive treatment option though with a high patient burden, making the impeding entry of psychedelics (psilocybin, LSD, DMT) into the market a serious threat.

15.04.2026

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments

13.04.2026

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Brainsway (BWAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Видео

No Data

There is no data to display

Пресс-релизы

15.04.2026

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

13.04.2026

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BURLINGTON, Mass. and JERUSALEM, April 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference at 8:45 AM ET on Wednesday, April 15, 2026.

19.03.2026

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

BrainsWay's investment is part of its ongoing strategy to partner with leading U.S. mental health providers to increase access to care BrainsWay's investment is part of its ongoing strategy to partner with leading U.S. mental health providers to increase access to care

04.03.2026

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

World's only FDA-cleared Deep TMS™ accelerated treatment reduces the acute phase of treatment by 70% World's only FDA-cleared Deep TMS™ accelerated treatment reduces the acute phase of treatment by 70%

BrainsWay Ltd. (BWAY)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

BrainsWay Ltd. (BWAY)

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

4 Medical Product Stocks to Buy From a Challenging Industry

BrainsWay: Competitive Threats Are Mounting

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Видео

No Data

Пресс-релизы

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

4 Medical Product Stocks to Buy From a Challenging Industry

BrainsWay: Competitive Threats Are Mounting

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Видео

No Data

Пресс-релизы

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Search stocks

BrainsWay Ltd. (BWAY)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

BrainsWay Ltd. (BWAY)

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

4 Medical Product Stocks to Buy From a Challenging Industry

BrainsWay: Competitive Threats Are Mounting

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Видео

No Data

Пресс-релизы

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

4 Medical Product Stocks to Buy From a Challenging Industry

BrainsWay: Competitive Threats Are Mounting

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Видео

No Data

Пресс-релизы

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment